ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,599Medicare Part D Prescriptions Filled, Including Refills

Rank: 178 out of 1111

$520K Total Retail Price of All Prescriptions

Rank: 206 out of 1111

397 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 397 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

33% of this provider’s 397 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

3% of this provider’s 7,290 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 762 551 S3 1 1
OMEPRAZOLE 327 254 2 4
POTASSIUM CHLORIDE 262 247 3 9
FUROSEMIDE 261 233 4 6
MELOXICAM 233 174 5 18
LEVOTHYROXINE SODIUM 229 182 6 3
GABAPENTIN 210 127 7 10
CITALOPRAM HBR 183 128 8 14
PRAVASTATIN SODIUM 170 139 9 17
LISINOPRIL 168 121 10 2
SIMVASTATIN 161 147 11 5
METFORMIN HCL 158 141 12 8
CARVEDILOL 153 125 13 21
TRAMADOL HCL 152 75 14 13
ZOLPIDEM TARTRATE 141 95 15 16
DONEPEZIL HCL 132 131 16 25
AMLODIPINE BESYLATE 131 120 17 7
POLYETHYLENE GLYCOL 3350 128 97 18 45
WARFARIN SODIUM 123 95 19 19
RANITIDINE HCL 117 102 20 29
CIPROFLOXACIN HCL 114 83 21 58
LYRICA 101 43 22 62
GLIMEPIRIDE 101 89 22 61
SULFAMETHOXAZOLE-TRIMETHOPRIM 100 77 24 71
NEXIUM 96 64 25 26
HYDROCHLOROTHIAZIDE 91 78 26 11
NAMENDA 89 89 27 31
CLOPIDOGREL 83 73 28 30
CYCLOBENZAPRINE HCL 82 38 R 29 37
METOPROLOL SUCCINATE 82 62 29 20
AZITHROMYCIN 81 63 31 39
NAPROXEN 79 51 32 85
METHYLPREDNISOLONE 78 58 33 93
FENTANYL 75 59 S2 34 65
PREDNISONE 65 48 35 48
CARBIDOPA-LEVODOPA 63 63 36 101
ISOSORBIDE MONONITRATE ER 62 46 37 73
METOPROLOL TARTRATE 60 52 38 12
PLAVIX 60 54 38 49
QUETIAPINE FUMARATE 59 56 40 76
COMBIVENT 58 58 41 129
LOSARTAN-HYDROCHLOROTHIAZIDE 56 52 42 72
VENLAFAXINE HCL ER 56 41 42 105
PROAIR HFA 55 42 44 38
ENALAPRIL MALEATE 54 49 45 56
OXYCODONE HCL-ACETAMINOPHEN 53 22 S2 46 86
PROMETHAZINE HCL 52 25 R 47 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 21, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.